{"id":"nicotine-0","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL3989563","moleculeType":"Small molecule","molecularWeight":"498.44"},"_dailymed":{"setId":"495b10ce-3d2d-1aa4-e063-6294a90a4f35","title":"FLOBOW QUIT SMOKING NICOTINE (NICOTINE18% MENTHOL 0.3% QUIT SMOKING NICOTINE) PATCH [JIANGXI YUDEXI PHARMACEUTICAL CO., LTD]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This product appears to be a non-active formulation containing no nicotine, likely used as a control or placebo comparator in clinical research settings. It may be designed to provide behavioral or sensory substitution (e.g., oral habit replacement) without delivering active nicotine, allowing researchers to isolate the pharmacological effects of nicotine from psychological or behavioral components of smoking or nicotine use.","oneSentence":"Nicotine 0% is a nicotine-free formulation that may serve as a placebo or behavioral substitute in smoking cessation or nicotine dependence research.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T06:40:33.320Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Smoking cessation (research/control use)"},{"name":"Nicotine dependence (research comparator)"}]},"trialDetails":[{"nctId":"NCT07042373","phase":"NA","title":"Effects of Tobacco Abuse Liability-dependent Taxes in the ETM","status":"NOT_YET_RECRUITING","sponsor":"Virginia Polytechnic Institute and State University","startDate":"2026-07-31","conditions":"Cigarette Smoking Behavior","enrollment":51},{"nctId":"NCT06885606","phase":"NA","title":"The Use of tDCS for Vaping Reduction","status":"RECRUITING","sponsor":"Centre for Addiction and Mental Health","startDate":"2026-01-01","conditions":"Vaping, Addiction, Transcranial Direct Current Stimulation(tDCS)","enrollment":40},{"nctId":"NCT05964010","phase":"NA","title":"Primary Connections for Youth and Families","status":"RECRUITING","sponsor":"The National Center on Addiction and Substance Abuse at Columbia University","startDate":"2024-03-01","conditions":"Substance Use","enrollment":2300},{"nctId":"NCT06620276","phase":"NA","title":"ACT_for Alcohol Use Disorder and Depression","status":"RECRUITING","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2025-05-01","conditions":"Depression - Major Depressive Disorder, Alcohol Use Disorder","enrollment":30},{"nctId":"NCT06863480","phase":"PHASE1","title":"Tocilizumab-aazg for Hemorrhage: Reduction of Ischemic Vascular Events","status":"RECRUITING","sponsor":"University of Florida","startDate":"2026-03-02","conditions":"Aneurysmal Subarachnoid Hemorrhage, Delayed Cerebral Ischemia","enrollment":30},{"nctId":"NCT05144542","phase":"NA","title":"Risk and Benefits of Electronic Cigarettes to Older Smokers at High Risk for Lung Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2022-03-07","conditions":"Lung Carcinoma","enrollment":140},{"nctId":"NCT07007195","phase":"EARLY_PHASE1","title":"Smart Olfaction App to Reduce Relapse","status":"NOT_YET_RECRUITING","sponsor":"University of Houston","startDate":"2026-03-23","conditions":"Nicotine Dependence","enrollment":132},{"nctId":"NCT07175402","phase":"NA","title":"Feasibility and Acceptability of an Online ACT Intervention for Disorders of Gut-Brain Interaction - Beta Trial","status":"COMPLETED","sponsor":"Örebro University, Sweden","startDate":"2025-09-08","conditions":"DGBI, Depression/Anxiety","enrollment":27},{"nctId":"NCT03461874","phase":"NA","title":"ACT Therapy for HF Migraine","status":"COMPLETED","sponsor":"Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta","startDate":"2018-03-15","conditions":"Migraine Without Aura","enrollment":64},{"nctId":"NCT04378907","phase":"NA","title":"Assessing Electronic Cigarette Nicotine Flux","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2021-01-05","conditions":"Electronic Cigarette Use","enrollment":33},{"nctId":"NCT06609083","phase":"PHASE1","title":"Effect of Cannabis on Cigarette Use Behavior","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2025-01-22","conditions":"Cannabis Use, Tobacco Use, Cigarette Smoking","enrollment":100},{"nctId":"NCT05766553","phase":"NA","title":"Effects of Mindfulness Meditation in Virtual Reality on Craving and Smoking Cessation","status":"RECRUITING","sponsor":"Centre Hospitalier Henri Laborit","startDate":"2023-06-15","conditions":"Tobacco Use Disorder","enrollment":200},{"nctId":"NCT05999383","phase":"PHASE2","title":"Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2025-07-01","conditions":"THC, Cannabis, Cannabis Use","enrollment":48},{"nctId":"NCT03630614","phase":"PHASE3","title":"Randomized Trial of Electronic Cigarettes With or Without Nicotine in Smoking Cessation.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2018-10-17","conditions":"Smoking Cessation, Smoking, Cigarette, Electronic Cigarette","enrollment":650},{"nctId":"NCT05271578","phase":"NA","title":"MRI and Biological Markers of Acute E-Cigarette Exposure in Smokers and Vapers","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2022-06-07","conditions":"Vascular Reactivity, Serum Biomarkers","enrollment":55},{"nctId":"NCT04755413","phase":"NA","title":"The Precision CAD Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Emory University","startDate":"2022-10-19","conditions":"Coronary Artery Disease","enrollment":276},{"nctId":"NCT06823518","phase":"NA","title":"Thrive Initiative Parent-Education Programming Study","status":"NOT_YET_RECRUITING","sponsor":"Penn State University","startDate":"2026-02-15","conditions":"Child Maltreatment, Parenting, Child Wellbeing","enrollment":480},{"nctId":"NCT06043362","phase":"NA","title":"Use of Nicotine Pouches Among Daily Smokers","status":"RECRUITING","sponsor":"Milton S. Hershey Medical Center","startDate":"2024-09-17","conditions":"Tobacco Dependence","enrollment":375},{"nctId":"NCT05205382","phase":"NA","title":"Assessing the Effect of Nicotine Reduction on ENDS User's Addiction and Exposures","status":"COMPLETED","sponsor":"Florida International University","startDate":"2022-04-01","conditions":"Electronic Cigarette Use","enrollment":116},{"nctId":"NCT04923685","phase":"","title":"MicroRNA Correlates of Childhood Maltreatment and Suicidality","status":"RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2021-02-26","conditions":"Major Depressive Disorder, Suicidal Ideation","enrollment":450},{"nctId":"NCT04058717","phase":"NA","title":"Low Nicotine Cigarettes Plus Electronic Cigarettes","status":"COMPLETED","sponsor":"Milton S. Hershey Medical Center","startDate":"2021-06-01","conditions":"Tobacco Dependence","enrollment":88},{"nctId":"NCT07001930","phase":"PHASE1","title":"Effects of Cannabidiol on Stress and Nicotine Withdrawal","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2025-08-25","conditions":"CBD, Stress, Nicotine Dependence","enrollment":90},{"nctId":"NCT04236791","phase":"NA","title":"The ESTxENDS Trial- Electronic Nicotine Delivery Systems as an Aid for Smoking Cessation-extension of Follow-up","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Bern","startDate":"2018-07-16","conditions":"Smoking Cessation","enrollment":1246},{"nctId":"NCT05430334","phase":"NA","title":"Assess the Influence of Nicotine Flux and Nicotine Form on Subjective Effects Related to Dependency","status":"COMPLETED","sponsor":"American University of Beirut Medical Center","startDate":"2022-07-13","conditions":"Nicotine Vaping, Nicotine Dependence, Nicotine Addiction","enrollment":130},{"nctId":"NCT04616768","phase":"PHASE3","title":"PROStep: A Feasibility Trial Using PROs and Step Data to Monitor Patients With Lung and GI Cancers","status":"COMPLETED","sponsor":"Abramson Cancer Center at Penn Medicine","startDate":"2020-11-19","conditions":"Cancer, Lung Cancer, Gastro-intestinal","enrollment":108},{"nctId":"NCT04432064","phase":"NA","title":"Temporal Interference Neurostimulation and Addiction","status":"TERMINATED","sponsor":"Indiana University","startDate":"2020-07-06","conditions":"Nicotine Use Disorder, Substance Use Disorders","enrollment":10},{"nctId":"NCT06239350","phase":"NA","title":"Young Adult Tobacco/Nicotine and Cannabis Co-use","status":"RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2024-05-13","conditions":"Tobacco Use Disorder, Nicotine Dependence","enrollment":350},{"nctId":"NCT06315881","phase":"PHASE2","title":"Informing Oral Nicotine Pouch Regulations to Promote Public Health","status":"RECRUITING","sponsor":"Ohio State University Comprehensive Cancer Center","startDate":"2025-01-13","conditions":"Tobacco-Related Carcinoma","enrollment":160},{"nctId":"NCT03552978","phase":"NA","title":"Tech and Telephone Smoking Cessation Treatment for Young Veterans With PTSD","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2019-02-13","conditions":"Smoking Cessation","enrollment":65},{"nctId":"NCT06609109","phase":"PHASE1","title":"Effect of Cannabis on E-Cigarette Use Behavior","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2025-03-19","conditions":"Cannabis Use, Tobacco Use, Electronic Cigarette Use","enrollment":100},{"nctId":"NCT03625986","phase":"NA","title":"Does Switching to Nicotine Containing Electronic Cigarettes Reduce Health Risk Markers","status":"COMPLETED","sponsor":"Milton S. Hershey Medical Center","startDate":"2022-04-22","conditions":"Tobacco Dependence","enrollment":105},{"nctId":"NCT05455086","phase":"NA","title":"Free-Base Nicotine or Nicotine Salt e-Liquids in Current E-Cigarette Smokers, PeloPET Study","status":"COMPLETED","sponsor":"Ohio State University Comprehensive Cancer Center","startDate":"2022-03-23","conditions":"Cigarette Smoking-Related Carcinoma","enrollment":21},{"nctId":"NCT04332926","phase":"NA","title":"Effects of E-Cigarette Nicotine Content in Smokers (Nicotine Flux Study)","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2021-01-05","conditions":"Electronic Cigarette Use","enrollment":44},{"nctId":"NCT01959607","phase":"NA","title":"Nicotine Pharmacokinetic Profile and Safety of the Tobacco Heating System 2.2 (THS 2.2)","status":"COMPLETED","sponsor":"Philip Morris Products S.A.","startDate":"2013-07","conditions":"Smoking","enrollment":65},{"nctId":"NCT05111041","phase":"NA","title":"Smokeless Tobacco Cessation Intervention for Firefighters","status":"COMPLETED","sponsor":"Duke University","startDate":"2022-01-25","conditions":"Smokeless Tobacco Cessation","enrollment":60},{"nctId":"NCT06675526","phase":"NA","title":"Detour: a Smartphone Game to Help Youth Quit Smoking","status":"RECRUITING","sponsor":"Behavioural Science Institute","startDate":"2024-07-05","conditions":"Smoking Cessation, Smoking Reduction, Adolescent Behavior","enrollment":604},{"nctId":"NCT06651684","phase":"NA","title":"Smoking Cessation Intervention Including Health Navigators to Address Unmet Social Needs of Parents Who Smoke","status":"NOT_YET_RECRUITING","sponsor":"St. Justine's Hospital","startDate":"2025-03-01","conditions":"Smoking Cessation, Tobacco Dependence","enrollment":1000},{"nctId":"NCT03384784","phase":"PHASE2","title":"Effect of Galantamine on Inflammation and Cognition","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2017-10-30","conditions":"HIV Associated Cognitive Motor Complex","enrollment":63},{"nctId":"NCT00385216","phase":"PHASE4","title":"Nicotine as an Adjuvant Analgesic for Third Molar Surgery","status":"COMPLETED","sponsor":"Columbia University","startDate":"2004-07","conditions":"Dental Crowding","enrollment":20},{"nctId":"NCT04038515","phase":"PHASE2","title":"Impact of Flavors on Nicotine Perception and Self-Administration Via E-cigarettes","status":"COMPLETED","sponsor":"Yale University","startDate":"2022-10-27","conditions":"Nicotine, E-liquid Flavors","enrollment":54},{"nctId":"NCT06459076","phase":"NA","title":"Application of THRIVE in Burn Children With Suspected Difficult Airway","status":"NOT_YET_RECRUITING","sponsor":"Shuxiu Wang","startDate":"2024-07-01","conditions":"Intubation; Difficult or Failed","enrollment":120},{"nctId":"NCT05439421","phase":"NA","title":"Consumer Perceptions of Waterpipe Tobacco Packaging and Digital Marketing Claims","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2022-10-25","conditions":"Waterpipe Tobacco Smoking","enrollment":1507},{"nctId":"NCT05157672","phase":"EARLY_PHASE1","title":"Evaluating the Pharmacokinetics and Drug Interaction Potential of the Botanical Dietary Supplement Cinnamon","status":"UNKNOWN","sponsor":"Washington State University","startDate":"2021-12-14","conditions":"Interaction Drug Food","enrollment":16},{"nctId":"NCT03011710","phase":"NA","title":"Epidemiology and Acute Oral Effects Electronic Cigarette","status":"COMPLETED","sponsor":"Semmelweis University","startDate":"2015-09","conditions":"Nicotine Dependence, Cigarettes","enrollment":14},{"nctId":"NCT02531594","phase":"NA","title":"An Intervention to Reduce Second Hand Smoke Exposure Among Pediatric Emergency Patients","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2016-04-06","conditions":"Smoking Cessation","enrollment":770},{"nctId":"NCT03742817","phase":"NA","title":"Effects of e-Cigarettes on Perceptions and Behavior","status":"COMPLETED","sponsor":"University of Southern California","startDate":"2019-02-01","conditions":"Electronic Cigarettes","enrollment":45},{"nctId":"NCT05333133","phase":"NA","title":"High Calorie Formula Intervention on Weight, Length Increment, Total Lymphocyte Counts, TNF-alpha and IGF-1 in Failure to Thrive Children","status":"COMPLETED","sponsor":"Universitas Airlangga","startDate":"2021-10-04","conditions":"Failure to Thrive, Infection, Bacterial, Growth Faltering","enrollment":80},{"nctId":"NCT05810298","phase":"NA","title":"Effects of Yoga on Pulmonary Parameters, Posture, Body Awareness and Quality of Life Among Chronic Smokers","status":"COMPLETED","sponsor":"Yeditepe University","startDate":"2022-12-22","conditions":"Smoking","enrollment":32},{"nctId":"NCT03897439","phase":"PHASE3","title":"Individualizing Pharmacotherapy for African American Smokers","status":"COMPLETED","sponsor":"University of Kansas Medical Center","startDate":"2019-05-01","conditions":"Smoking Cessation","enrollment":392},{"nctId":"NCT05484505","phase":"EARLY_PHASE1","title":"Preloaded Combination Nicotine Replacement Therapy on Smoking Cessation of Adult Population in Kazakhstan","status":"UNKNOWN","sponsor":"Nazarbayev University","startDate":"2023-07-01","conditions":"Smoking Cessation, Smoking, Cigarette, Smoking Behaviors","enrollment":200},{"nctId":"NCT02603133","phase":"NA","title":"Web-based Implementation for the Science of Enhancing Resilience Study","status":"COMPLETED","sponsor":"Stanford University","startDate":"2016-07","conditions":"Burnout, Professional, Resilience, Psychological","enrollment":2650},{"nctId":"NCT03861078","phase":"NA","title":"The Effect of Electronic Cigarette Liquid Characteristics in Smokers.","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2020-02-17","conditions":"Electronic Cigarettes","enrollment":22},{"nctId":"NCT05289674","phase":"NA","title":"The Effect of Lactoferrin in High Calorie Formula on IL-6 and IL10 in Children With Failure to Thrive and Infection","status":"COMPLETED","sponsor":"Universitas Airlangga","startDate":"2021-10-04","conditions":"Failure to Thrive, Infections","enrollment":75},{"nctId":"NCT02124187","phase":"NA","title":"Smoking Cessation And Reduction in Depression","status":"UNKNOWN","sponsor":"Universita degli Studi di Catania","startDate":"2022-12","conditions":"Tobacco Smoking in Depressed Patients","enrollment":129},{"nctId":"NCT01979796","phase":"NA","title":"Antismoking Effects of Electronic Cigarettes in Subjects With Schizophrenia and Their Potential Influence on Cognitive Functioning.","status":"UNKNOWN","sponsor":"Universita degli Studi di Catania","startDate":"2022-12","conditions":"Tobacco Smoking in Schizophrenic Patients","enrollment":153},{"nctId":"NCT05180643","phase":"NA","title":"Mindfulness Meditation (MBSR) and Parkinson's Disease (PD)","status":"COMPLETED","sponsor":"University Hospital, Bordeaux","startDate":"2020-02-17","conditions":"Parkinson Disease","enrollment":31},{"nctId":"NCT03084315","phase":"NA","title":"Changes in Biomarkers Associated With Use of Electronic Cigarettes","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2016-11-15","conditions":"Biomarkers","enrollment":234},{"nctId":"NCT04192032","phase":"NA","title":"Assessing the Effect of Flavor on ENDS Users' Experiences and Exposures","status":"COMPLETED","sponsor":"Florida International University","startDate":"2018-11-15","conditions":"Electronic Cigarette Use","enrollment":41},{"nctId":"NCT03674970","phase":"PHASE1, PHASE2","title":"Effects of Random Nicotine Delivery on Smoking Cessation","status":"COMPLETED","sponsor":"Milton S. Hershey Medical Center","startDate":"2019-03-12","conditions":"Smoking Cessation, Cigarette Smoking, Smoking (Tobacco) Addiction","enrollment":45},{"nctId":"NCT02600273","phase":"NA","title":"Novel Approaches to Reducing Tobacco Related Harm","status":"COMPLETED","sponsor":"Duke University","startDate":"2017-01","conditions":"Smoking, Tobacco Smoking Behavior, Cigarette Smoking","enrollment":18},{"nctId":"NCT01008748","phase":"NA","title":"Determinants of Smoking Cessation Among Latinos","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2009-09","conditions":"Smoking Cessation","enrollment":200},{"nctId":"NCT01967706","phase":"NA","title":"Nicotine Pharmacokinetic Profile and Safety of the Tobacco Heating System 2.2 Menthol (THS 2.2 Menthol).","status":"COMPLETED","sponsor":"Philip Morris Products S.A.","startDate":"2013-08","conditions":"Smoking","enrollment":73},{"nctId":"NCT01967719","phase":"NA","title":"Nicotine Pharmacokinetic Profile and Safety of the Tobacco Heating System 2.2 Menthol (THS 2.2 Menthol)","status":"COMPLETED","sponsor":"Philip Morris Products S.A.","startDate":"2013-10","conditions":"Smoking","enrollment":64},{"nctId":"NCT01967732","phase":"NA","title":"Nicotine Pharmacokinetic Profile and Safety of the Tobacco Heating System 2.2 (THS 2.2)","status":"COMPLETED","sponsor":"Philip Morris Products S.A.","startDate":"2013-11","conditions":"Smoking","enrollment":62},{"nctId":"NCT02628964","phase":"NA","title":"Electronic Cigarettes (E-cigarettes) as a Harm Reduction Strategy","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2015-05","conditions":"Tobacco Use Disorder, Smoking","enrollment":100},{"nctId":"NCT03174158","phase":"PHASE4","title":"A Text Messaging Program for Smokers in Primary Care","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2017-11-06","conditions":"Smoking Cessation","enrollment":153},{"nctId":"NCT03606655","phase":"PHASE1","title":"Exploring the Impact of Two-week Kava on the Metabolism of Nicotine and NNK","status":"WITHDRAWN","sponsor":"University of Florida","startDate":"2020-01","conditions":"Kava on the Metabolism of Nicotine and NNK","enrollment":""},{"nctId":"NCT01756885","phase":"PHASE3","title":"Extended Varenicline Treatment for Smoking Among Cancer Patients","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2013-01","conditions":"Nicotine Dependence","enrollment":207},{"nctId":"NCT00736255","phase":"NA","title":"Attention Deficit Hyperactivity Disorder (ADHD) Smoking Cessation Study","status":"COMPLETED","sponsor":"Duke University","startDate":"2007-12","conditions":"Attention Deficit Hyperactivity Disorder, Nicotine Dependence","enrollment":32},{"nctId":"NCT03209661","phase":"PHASE1","title":"Vascular Effects of a Single Bout of Electronic Cigarette Use","status":"COMPLETED","sponsor":"University of Texas at Austin","startDate":"2017-04-28","conditions":"Arterial Stiffness","enrollment":16},{"nctId":"NCT02342795","phase":"PHASE1, PHASE2","title":"Randomized Controlled Trial Methods for Novel Tobacco Products Evaluation","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2015-06","conditions":"Nontherapeutic","enrollment":520},{"nctId":"NCT02239770","phase":"NA","title":"Pharmacokinetics of Nicotine Film in Smokers","status":"COMPLETED","sponsor":"Milton S. Hershey Medical Center","startDate":"2015-09","conditions":"Smoking Cessation","enrollment":24},{"nctId":"NCT00440505","phase":"PHASE4","title":"Effect of Nicotine on Chronic Pelvic Pain","status":"COMPLETED","sponsor":"Columbia University","startDate":"2004-02","conditions":"Pelvic Pain","enrollment":20},{"nctId":"NCT03010995","phase":"PHASE1","title":"The Acute Cardiovascular Effects of Nicotine in E-cigarettes (ACE) Study","status":"WITHDRAWN","sponsor":"University of Louisville","startDate":"2018-03-13","conditions":"Cigarette Smoking Toxicity, Nicotine, Acute Cardiovascular Disease","enrollment":""},{"nctId":"NCT00664755","phase":"PHASE2","title":"Menstrual Cycle Effects on Smoking Cessation and Cue Reactivity","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2007-07","conditions":"Nicotine Dependence","enrollment":140},{"nctId":"NCT03178422","phase":"PHASE2","title":"Safety and Efficacy Study of the NRT CQSS2 System for Smoking Cessation in Treatment-Seeking Subjects","status":"COMPLETED","sponsor":"Chrono Therapeutics, Inc.","startDate":"2017-08-07","conditions":"Smoking Cessation","enrollment":220},{"nctId":"NCT01395797","phase":"PHASE1, PHASE2","title":"Pioglitazone for Heroin and for Nicotine Dependence","status":"TERMINATED","sponsor":"New York State Psychiatric Institute","startDate":"2011-03","conditions":"Heroin Dependence, Nicotine Dependence","enrollment":82},{"nctId":"NCT00258479","phase":"PHASE1","title":"Safety of Combining Modafinil and Nicotine Replacement Therapy in Treating Nicotine Dependent Adolescents","status":"COMPLETED","sponsor":"Catherine Martin, MD","startDate":"2003-06","conditions":"Tobacco Use Disorder","enrollment":24},{"nctId":"NCT00087880","phase":"PHASE2","title":"Maintaining Abstinence in Chronic Cigarette Smokers - 1","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2002-12","conditions":"Tobacco Use Disorder","enrollment":407},{"nctId":"NCT00218413","phase":"PHASE2","title":"Safety and Effectiveness of NicVAX in Treating Nicotine Dependent Individuals","status":"COMPLETED","sponsor":"Nabi Biopharmaceuticals","startDate":"2004-10","conditions":"Smoking Cessation, Tobacco Use Cessation","enrollment":51},{"nctId":"NCT00218231","phase":"PHASE2","title":"Effect of Bupropion on Smoking Behavior in Smokers With Schizophrenia","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2004-01","conditions":"Schizophrenia, Tobacco Use Disorder","enrollment":48},{"nctId":"NCT01310842","phase":"","title":"Social Determinants and Smoking Cessation","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2012-07","conditions":"Smoking Cessation","enrollment":329},{"nctId":"NCT00935818","phase":"PHASE2, PHASE3","title":"Varenicline and Bupropion for Smoking Cessation","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2009-09","conditions":"Smoking","enrollment":506},{"nctId":"NCT00995033","phase":"PHASE2","title":"Efficacy and Safety of NicVAX® Co-administered With Varenicline (Champix®)","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2009-10","conditions":"Smoking Behavior, Smoking Lapse Behavior, Smoking Relapse Behavior","enrollment":558},{"nctId":"NCT00390559","phase":"NA","title":"Examining the Effect of the Nicotine Patch in Male and Female Smokers - 3","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2005-10","conditions":"Drug Addiction, Smoking Cessation","enrollment":80},{"nctId":"NCT01188018","phase":"PHASE3","title":"Testing Counseling Styles to Motivate Smokers to Quit","status":"COMPLETED","sponsor":"University of Missouri, Kansas City","startDate":"2010-10","conditions":"Smoking, Tobacco Use, Nicotine Dependence","enrollment":255},{"nctId":"NCT01204723","phase":"PHASE1","title":"Medications Development for the Treatment of Cannabis Related Disorders","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2009-08","conditions":"Nicotine Withdrawal, Marijuana Dependence, Cannabis Dependence","enrollment":63},{"nctId":"NCT00598325","phase":"PHASE1, PHASE2","title":"Antibody and Safety Study of 6 Doses of NicVAX in Smokers","status":"COMPLETED","sponsor":"Nabi Biopharmaceuticals","startDate":"2008-01","conditions":"Smoking","enrollment":74},{"nctId":"NCT01296698","phase":"PHASE3","title":"Study to Determine if a New Nicotine Replacement Therapy Can Safely Help Smokers to Quit Smoking","status":"TERMINATED","sponsor":"McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.","startDate":"2011-03","conditions":"Tobacco Dependence","enrollment":257},{"nctId":"NCT00818207","phase":"PHASE4","title":"Impact Of Smoking Cessation Treatment Reimbursement On The Quit Rates In Smokers Motivated To Quit","status":"COMPLETED","sponsor":"Pfizer","startDate":"2009-03","conditions":"Smoking Cessation, Insurance Coverage","enrollment":1380},{"nctId":"NCT00633321","phase":"PHASE2","title":"Study of TA-NIC to Assess the Efficacy and Safety of the Vaccine as an Aid to Smoking Cessation","status":"COMPLETED","sponsor":"Celtic Pharma Development Services","startDate":"2007-05","conditions":"Smoking","enrollment":522}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Placebo"],"phase":"marketed","status":"active","brandName":"Nicotine 0%","genericName":"Nicotine 0%","companyName":"University of Texas at Austin","companyId":"university-of-texas-at-austin","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Nicotine 0% is a nicotine-free formulation that may serve as a placebo or behavioral substitute for nicotine dependence without delivering active nicotine. Used for Smoking cessation support (behavioral component).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}